Kura Oncology (KURA)
NASDAQ:KURA
Holding KURA?
Track your performance easily

Kura Oncology (KURA) Ownership - Who Owns Kura Oncology?

491 Followers

Kura Oncology (KURA) Ownership Overview

1.17%10.91%2.12%12.83%72.96%
2.12% Other Institutional Investors
12.83% ETFs
72.96% Public Companies and
Individual Investors
The ownership structure of Kura Oncology (KURA) stock is a mix of institutional, retail, and individual investors. Approximately 25.86% of the company’s stock is owned by Institutional Investors, 1.17% is owned by Insiders, and 72.96% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 31, 2024
xxxxxxxxxxxxx
$36543
Jan 31, 2024
Thomas James Doyle
Svp, Finance & Accounting
xxxxxxxxxxxxx
$41260
Jan 31, 2024
xxxxxxxxxxxxx
$127412

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$862185
Jun 30, 2024
xxxxxxxxxxxxx
$2948632

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,411,571Institution6.96%95,027,187
3,927,490Institution5.05%68,966,724
3,410,731Institution4.39%59,892,436
3,240,573Institution4.17%56,904,462
1,137,515Institution1.46%19,974,763
967,982Institution1.24%16,997,764
840,707Institution1.08%14,762,815
810,705Institution1.04%14,235,980
579,753Insider0.75%10,180,463
413,995Institution0.53%7,269,752

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,240,573Institution4.17%56,904,462
967,982Institution1.24%16,997,764
840,707Institution1.08%14,762,815
810,705Institution1.04%14,235,980
384,320Institution0.49%6,748,659
367,822Institution0.47%6,458,954
360,159Institution0.46%6,324,392
285,998Institution0.37%5,022,125
211,647Institution0.27%3,716,521
165,465Institution0.21%2,905,565

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,165,680Institution2.78%42,317,387
1,993,321Institution2.56%35,002,717
1,189,544Institution1.53%23,243,690
1,031,097Institution1.33%18,229,795
651,150Institution0.84%11,434,194
456,957Institution0.59%8,024,165
373,099Institution0.48%6,596,390
332,587Institution0.43%6,498,750
186,922Institution0.24%3,304,781
152,475Institution0.20%2,979,362

FAQ

Who Owns Kura Oncology (KURA)?
According to the latest TipRanks data, approximately 2.12% of the company's stock is held by institutional investors, 1.17% is held by insiders, and 72.96% is held by retail investors.
    What percentage of Kura Oncology (KURA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.12% of Kura Oncology (KURA) stock is held by institutional investors.
      What percentage of Kura Oncology (KURA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 72.96% of Kura Oncology (KURA) stock is held by retail investors.
        Who owns the most shares of Kura Oncology (KURA)?
        James E. Flynn owns the most shares of Kura Oncology (KURA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis